8-K - Septerna, Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

of this Current Report on Form 8-K, including the accompanying Exhibits 99.1 and 99.2, is intended to be furnished and shall not be deemed “filed” for purposes

Regulation Fd

8.01

. Other Events On March 1, 2026, the Company announced positive results from its Phase 1 clinical trial evaluating SEP-631, a potent and selective oral negative

Other Event

9.01

. Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release issued by Septerna, Inc. on March 1, 2026, furnished herewith. 99.2 Corporate Presentation

Exhibits Only

Exhibits (3)

8-K

99.1

EX-99.1

99.2

EX-99.2